Northrop Grumman Corp.NOC
Closing prices as of Oct 26, 2026Updated once daily after the US close — not a live quote.

$566.65

+10.89% past month

Notable price movement

  • Oct 26, 2026

    $565.41+2.53%

    Northrop Grumman rose 2.53% as comparable listed companies in search, detection, navigation, guidance and aeronautical systems moved up 1.77% on average . Three of the five rose and two fell, with LHX up 2.46%, TDY up 3.21% and DRS up 3.85% . The move was largely shared with that group.

  • Oct 23, 2026

    $551.44-0.16%

  • Oct 22, 2026

    $552.35+2.42%

    Comparable listed companies moved -0.10% on average, with 2 of 5 falling and 3 rising, so Northrop Grumman's move was not shared by that group . 24/7 Wall St reported that Lockheed Martin's record backlog and guidance raises pulled defense shares higher and that Northrop Grumman advanced . Seeking Alpha published an analysis of Northrop Grumman's Q3 2026 results, citing a record backlog .

  • Oct 21, 2026

    $539.31+0.99%

  • Oct 20, 2026

    $534.00+4.57%

    Northrop Grumman released its third quarter 2026 financial results that day . The Motley Fool reported that CEO Kathy Warden saw "unprecedented levels of demand" for the company's military technology , and a Motley Fool transcript summary cited a record $110B backlog and raised guidance . Comparable listed companies moved +0.02% on average, so the stock's gain was not shared by that group . Volume was 2.0x the trailing average .

  • Oct 19, 2026

    $510.65-1.77%

    Comparable listed companies fell 0.45% on average, and Northrop Grumman fell with them, though by a larger margin .

  • Oct 16, 2026

    $519.86+4.05%

    Northrop Grumman rose 4.05%, while comparable listed companies moved -0.80% on average, with 4 of 5 falling and 1 rising . The move was therefore not shared by the cohort, which was slightly lower on the day .

Closing prices for NOC. Summaries describe past sessions only and are not advice, a forecast or a recommendation.

Prices and financial data are historical and provided for research only. Not investment advice.